Skip to main content

Table 1 Baseline characteristics of the study population

From: Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden

Characteristic (n = 122)

Value (N (%))

Demographics

 

 Age (years), mean ± SD

61.35 ± 11.72

 Male

82 (67.2)

 Black

11 (9.0)

Blood pressure (mmHg), mean ± SD

 

 Systolic blood pressure

127.97 ± 23.01

(n = 118)

 Diastolic blood pressure

70.19 ± 13.29

(n = 118)

Medical history

 

 Acute coronary syndrome on presentation

43 (35.2)

 Prior myocardial infarction

36 (29.5)

 Hypertension

95 (77.9)

 Diabetes

46 (37.7)

 Chronic dialysis

8 (6.6)

 Congestive heart failure

32 (26.2)

 Chronic obstructive lung disease

8 (6.6)

 Peripheral vascular disease

10 (8.2)

 Hyperlipidemia

91 (74.6)

 Current Smoker

12 (10.3)

(n = 116)

Medications

 

 Aspirin

98 (80.3)

 Plavix

39 (32.0)

 Statins

87 (71.3)

 ACE/ARB

65 (53.3)

 β-blocker

86 (70.5)

Angiographic Findings

 

 Number of diseased vessels, median [IQR]

1 [0.0, 2.0]

 Multi-vessel coronary disease

34 (27.9)

 Percent area stenosis (%), median [IQR]

4.96 [3.78, 6.37]

 Gensini Score

26.0 [19.5, 39.0]

Labs, mean ± SD

 

 Ejection Fraction (%), median [IQR]

57.0 [45.0, 65.0]

(n = 81)

 Hemoglobin, (g/dL)

13.17 ± 1.85

(n = 119)

 White blood count (1000/mm3), median [IQR]

7.83 [6.22, 9.04]

(n = 120)

 LDL cholesterol (mg/dL)

86.76 ± 36.23

(n = 98)

 Serum creatinine (mg/dL), [median IQR]

1.05 [0.84, 1.30]

 Estimated glomerular filtration rate, (mL/min)

68.33 ± 30.41

  1. Baseline characteristics of the study population
  2. SD standard deviation, IQR inter-quartile range, Hg mercury, min minute. ACE/ARB angiotensin converting enzyme inhibitor/angiotensin receptor blocker